Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells
Open Access
- 8 September 2014
- journal article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (9), e103887
- https://doi.org/10.1371/journal.pone.0103887
Abstract
The prognosis of patients with ovarian cancer has remained poor mainly because of aggressive cancer progression. Since epithelial-mesenchymal transition (EMT) is an important mechanism mediating invasion and metastasis of cancer cells, targeting the EMT process with more efficacious and less toxic compounds to inhibit metastasis is of great therapeutic value for the treatment of ovarian cancer. We have found for the first time that the ginsenoside 20(S)-Rg3, a pharmacologically active component of the traditional Chinese herb Panax ginseng, potently blocks hypoxia-induced EMT of ovarian cancer cells in vitro and in vivo. Mechanistic studies confirm the mode of action of 20(S)-Rg3, which reduces the expression of hypoxia-inducible factor 1α (HIF-1α) by activating the ubiquitin-proteasome pathway to promote HIF-1α degradation. A decrease in HIF-1α in turn leads to up-regulation, via transcriptional suppression of Snail, of the epithelial cell-specific marker E-cadherin and down-regulation of the mesenchymal cell-specific marker vimentin under hypoxic conditions. Importantly, 20(S)-Rg3 effectively inhibits EMT in nude mouse xenograft models of ovarian cancer, promising a novel therapeutic agent for anticancer therapy.This publication has 45 references indexed in Scilit:
- AMP-activated protein kinase: An emerging target for ginsengJournal of Ginseng Research, 2014
- Ginsenoside Rg1 Induces Apoptosis through Inhibition of the EpoR-Mediated JAK2/STAT5 Signalling Pathway in the TF-1/Epo Human Leukemia Cell LineAsian Pacific Journal of Cancer Prevention, 2014
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene, 2010
- Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κBEuropean Journal of Pharmacology, 2010
- Ginseng Compounds: An Update on their Molecular Mechanisms and Medical ApplicationsCurrent Vascular Pharmacology, 2009
- Epithelial-Mesenchymal Transition: A Cancer Researcher's Conceptual Friend and FoeThe American Journal of Pathology, 2009
- Reassessing Epithelial to Mesenchymal Transition as a Prerequisite for Carcinoma Invasion and MetastasisCancer Research, 2006
- The angiosuppressive effects of 20(R)- ginsenoside Rg3Biochemical Pharmacology, 2006
- Tumor microenvironmental physiology and its implications for radiation oncologySeminars in Radiation Oncology, 2004
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl HydroxylationScience, 2001